- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04132219
Daughters, dUdes, Mothers and othErs Fighting Cancer Together (DUET)
Daughters, (dUdes), Mothers and othErs Fighting Cancer Together
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The specific aims of this protocol are to: 1) determine whether dyads (comprised of an overweight / obese cancer survivor and an overweight / obese buddy of his or her choosing) lose significantly more weight (kg) at 6-months when assigned to the eHealth intervention compared to a wait-listed control; 2) explore between-arm differences in score changes between baseline and 6-month follow-up for other key outcomes including measures of adiposity (e.g., waist circumference [WC] and body mass index [BMI]), blood pressure, diet quality, physical activity, health-related Quality of Life (QoL), physical functioning and performance; 3) Assess the impact of the intervention on select biomarkers associated with cancer risk and progression, e.g., tumor TNFα, insulin and IGF-1; and, 4) identify predictor variables associated with program efficacy, e.g., social support, self-efficacy, risk for depression, and dyad partner (spouse, relative, friend/neighbor).
Cancer survivors and their selected "buddies" who are interested in participating will be directed to a website that describes this study in detail. If interested, they will be asked to complete an online screener requiring information on race/ethnicity, gender, state of residence and eligibility criteria. Once interested participants are assessed for eligibility, consented and enrolled, they will be asked to complete online questionnaires that assess physical activity, dietary intake, health-related quality of life, risk for depression, self-efficacy, social support and barriers to diet resources. Finally, anthropometric measures, blood pressure, physical performance and circulating biomarkers will be collected in participants' homes by visiting study staff (whom the project manager will deploy after checking for a mutually convenient time for the 2-person dyad.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- UAB School of Health Professions, Department of Nutrition Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults age 18+ for whom at least one dyad member has been diagnosed and completed curative treatment for localized renal cancer, or loco-regional ovarian, colorectal, endometrial, or female breast cancer. (Loco-regional prostate cancer survivors are also eligible but could be on active surveillance).
- Diagnosed as overweight or obese (BMI >25 kg/m2.
- Low vegetable and fruit intake (<2.5 cups day).
- Low physical activity (<150 minutes per week).
- English-speaking and writing.
- Completed at least 5th grade.
- Uses the internet and owns a mobile phone.
Exclusion Criteria:
- Diagnosed with uncontrolled chronic conditions (i.e., diabetes, blood pressure, CVD, etc)
- Diagnosed with a health conditions that precludes adherence to an unsupervised weight loss intervention (e.g., pregnancy, end-stage renal disease, etc).
- Instructed by a physician to limit physical activity AND have paralysis, dementia, blindness, unstable angina, untreated stage 3 hypertension, or recent history of heart attack, congestive heart failure or pulmonary conditions that required oxygen or hospitalization within 6 months.
- Diagnosed with other cancers (except non-malignant skin cancer), cancer recurrence or metastatic disease.
- Resides in a skilled nursing or assisted living facility.
- Resides more than 15 minute driving distance from dyad partner.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Immediate Intervention Group
Dyads randomized to the Immediate Intervention Group will receive a "Welcome Box" at completion of the baseline assessment.
The Welcome Box will include two of each of the following: 1) Letters describing the project logistics and the important roles of each dyad member); 2) WiFi-enabled Scales (with instructions to weigh daily); 3) Portion Doctor ®Tableware (with instructions to use the portion plates at least once a day); 4) Fitbit® Inspire Activity Monitors (with instructions to share data with the dyad member and the study office); and 5) Instructions on how to create a secured account on the DUET website and instructions for logging on.
|
Every week, each dyad member will receive a tailored text message that provides a new fun fact or that encourages them to log-on to the website to access findings of new research and how the results might apply to them.
They will be directed to specific pages in the Web-based program and asked to select strategies from a list that they will practice during the upcoming week.
Graphic displays of their progress will be provided along with SCT-based feedback.
They will be directed to the website to record their behavioral goals for the upcoming week.
Tips also will be provided for effective communication to enhance couple efficacy.
All usage will be tracked to assess adherence.
|
|
Other: Delayed Intervention Group
Participants assigned to the Delayed Intervention Group will receive a "Welcome Box" which on the outside is identical (and also is comparably weighted with bottled water) to that given to the Immediate Intervention group.
This box would include: 1) Letters describing the project logistics and the important roles of each dyad member; and 2) monthly online study newsletters on topics unrelated to diet and exercise, but still of interest to cancer survivors and dyad members such as coping with stress, reducing exposure to radiation, sun safety, etc. to enhance retention and will be offered the opportunity to receive the online intervention after completing final 6-month assessments.
|
Every week, each dyad member will receive a tailored text message that provides a new fun fact or that encourages them to log-on to the website to access findings of new research and how the results might apply to them.
They will be directed to specific pages in the Web-based program and asked to select strategies from a list that they will practice during the upcoming week.
Graphic displays of their progress will be provided along with SCT-based feedback.
They will be directed to the website to record their behavioral goals for the upcoming week.
Tips also will be provided for effective communication to enhance couple efficacy.
All usage will be tracked to assess adherence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Weight
Time Frame: baseline
|
Change in measured body weight
|
baseline
|
|
Body Weight
Time Frame: 6 months
|
Change in measured body weight
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Waist Circumference
Time Frame: baseline
|
measured with a non-stretch tape
|
baseline
|
|
Waist Circumference
Time Frame: 6 months
|
measured with a non-stretch tape
|
6 months
|
|
Physical Activity (self-reported)
Time Frame: Baseline
|
Godin Leisure Time Physical Activity Questionnaire (4-item survey) - individuals provide the number of minutes of vigorous, moderate and light physical activity per week.
The minimum is 0 - theoretically, the maximum is 10,080 (the number of minutes in a week), then they are asked if this level of activity is "typical."
The higher the number of minutes of totaled moderate + vigorous activity, the better.
|
Baseline
|
|
Physical Activity (self-reported)
Time Frame: 3 months
|
Godin Leisure Time Physical Activity Questionnaire (4-item survey) - individuals provide the number of minutes of vigorous, moderate and light physical activity per week.
The minimum is 0 - theoretically, the maximum is 10,080 (the number of minutes in a week), then they are asked if this level of activity is "typical."
The higher the number of minutes of totaled moderate + vigorous activity, the better.
|
3 months
|
|
Physical Activity (self-reported)
Time Frame: 6 months
|
Godin Leisure Time Physical Activity Questionnaire (4-item survey) - individuals provide the number of minutes of vigorous, moderate and light physical activity per week.
The minimum is 0 - theoretically, the maximum is 10,080 (the number of minutes in a week), then they are asked if this level of activity is "typical."
The higher the number of minutes of totaled moderate + vigorous activity, the better.
|
6 months
|
|
Physical Activity (objective)
Time Frame: baseline
|
Accelerometry (7-day assessment)
|
baseline
|
|
Physical Activity (objective)
Time Frame: 6 months
|
Accelerometry (7-day assessment)
|
6 months
|
|
Diet Quality
Time Frame: baseline
|
Two 24-hour dietary recalls
|
baseline
|
|
Diet Quality
Time Frame: 6 months
|
Two 24-hour dietary recalls
|
6 months
|
|
Physical Performance (endurance)
Time Frame: Baseline
|
2-minute step test
|
Baseline
|
|
Physical Performance (endurance)
Time Frame: 6 months
|
2-minute step test
|
6 months
|
|
Physical Performance (lower body strength)
Time Frame: Baseline
|
30-second chair stand
|
Baseline
|
|
Physical Performance (lower body strength)
Time Frame: 6 months
|
30-second chair stand
|
6 months
|
|
Physical Performance (agility)
Time Frame: Baseline
|
8' foot up and go
|
Baseline
|
|
Physical Performance (agility)
Time Frame: 6 months
|
8' foot up and go
|
6 months
|
|
Physical Performance (gait speed)
Time Frame: baseline
|
8' walk
|
baseline
|
|
Physical Performance (gait speed)
Time Frame: 6 months
|
8' walk
|
6 months
|
|
Physical Performance (Balance)
Time Frame: baseline
|
Side-by-side, semi-tandem and tandem stances
|
baseline
|
|
Physical Performance (Balance)
Time Frame: 6 months
|
Side-by-side, semi-tandem and tandem stances
|
6 months
|
|
Self-efficacy for calorically restricted diet
Time Frame: baseline
|
Clark et al. survey (20 items).
Respondents either affirm or deny that they can resist high fat, high calorie foods under a variety of situations.
Individuals who have maximum willpower achieve the top score of 20, whereas those with lesser willpower score lower (the minimum score is zero)
|
baseline
|
|
Self-efficacy for calorically restricted diet
Time Frame: 3 months
|
Clark et al. survey (20 items).
Respondents either affirm or deny that they can resist high fat, high calorie foods under a variety of situations.
Individuals who have maximum willpower achieve the top score of 20, whereas those with lesser willpower score lower (the minimum score is zero)
|
3 months
|
|
Self-efficacy for calorically restricted diet
Time Frame: 6 months
|
Clark et al. survey (20 items).
Respondents either affirm or deny that they can resist high fat, high calorie foods under a variety of situations.
Individuals who have maximum willpower achieve the top score of 20, whereas those with lesser willpower score lower (the minimum score is zero)
|
6 months
|
|
Self-efficacy for increased physical activity
Time Frame: baseline
|
Sallis et al. survey (6 items in total).
Respondents rate themselves on each item from 0 to 100% on their level of confidence.
The higher the total score (maximum of 100%) the better (Minimum 0%).
|
baseline
|
|
Self-efficacy for increased physical activity
Time Frame: 3 months
|
Sallis et al. survey (6 items in total).
Respondents rate themselves on each item from 0 to 100% on their level of confidence.
The higher the total score (maximum of 100%) the better (Minimum 0%).
|
3 months
|
|
Self-efficacy for increased physical activity
Time Frame: 6 months
|
Sallis et al. survey (6 items in total).
Respondents rate themselves on each item from 0 to 100% on their level of confidence.
The higher the total score (maximum of 100%) the better (Minimum 0%).
|
6 months
|
|
Social support for calorically restricted diet
Time Frame: baseline
|
Sallis et al. instrument (4 items).
Respondents rate the level of support they obtain to follow a healthy, low calorie diet on a 5-point scale ranging from ("never"= 0 to "everyday" = 4. Individuals who have maximum support achieve the top score of 16, whereas those with lesser support score lower (the minimum score is zero)
|
baseline
|
|
Social support for increased physical activity
Time Frame: baseline
|
Sallis et al. instrument (4 items in total) Respondents rate the level of support they obtain to increase their level of physical activity on a 5-point scale ranging from ("never"= 0 to "everyday" = 4. Individuals who have maximum support achieve the top score of 16, whereas those with lesser support score lower (the minimum score is zero)
|
baseline
|
|
Social support for calorically restricted diet
Time Frame: 3 months
|
Sallis et al. instrument (4 items).
Respondents rate the level of support they obtain to follow a healthy, low calorie diet on a 5-point scale ranging from ("never"= 0 to "everyday" = 4. Individuals who have maximum support achieve the top score of 16, whereas those with lesser support score lower (the minimum score is zero)
|
3 months
|
|
Social support for increased physical activity
Time Frame: 3 months
|
Sallis et al. instrument (4 items in total) Respondents rate the level of support they obtain to increase their level of physical activity on a 5-point scale ranging from ("never"= 0 to "everyday" = 4. Individuals who have maximum support achieve the top score of 16, whereas those with lesser support score lower (the minimum score is zero)
|
3 months
|
|
Social support for calorically restricted diet
Time Frame: 6 months
|
Sallis et al. instrument (4 items).
Respondents rate the level of support they obtain to follow a healthy, low calorie diet on a 5-point scale ranging from ("never"= 0 to "everyday" = 4. Individuals who have maximum support achieve the top score of 16, whereas those with lesser support score lower (the minimum score is zero)
|
6 months
|
|
Social support for increased physical activity
Time Frame: 6 months
|
Sallis et al. instrument (4 items in total) Respondents rate the level of support they obtain to increase their level of physical activity on a 5-point scale ranging from ("never"= 0 to "everyday" = 4. Individuals who have maximum support achieve the top score of 16, whereas those with lesser support score lower (the minimum score is zero)
|
6 months
|
|
Barriers for increased physical activity
Time Frame: baseline
|
(15 items in total) Respondents either affirm or deny common barriers to exercise.
Individuals who report more barriers achieve the top score of 21, whereas those with fewer barriers score lower (the minimum score is zero) and that is considered better.
|
baseline
|
|
Barriers for increased physical activity
Time Frame: 3 months
|
(15 items in total) Respondents either affirm or deny common barriers to exercise.
Individuals who report more barriers achieve the top score of 21, whereas those with fewer barriers score lower (the minimum score is zero) and that is considered better.
|
3 months
|
|
Barriers for increased physical activity
Time Frame: 6 months
|
(15 items in total) Respondents either affirm or deny common barriers to exercise.
Individuals who report more barriers achieve the top score of 21, whereas those with fewer barriers score lower (the minimum score is zero) and that is considered better.
|
6 months
|
|
Circulating insulin
Time Frame: baseline
|
assays on dried blood spot eluents
|
baseline
|
|
Circulating insulin
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
|
Circulating glucose
Time Frame: baseline
|
assays on dried blood spot eluents
|
baseline
|
|
Circulating glucose
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
|
Circulating IL-6
Time Frame: baseline
|
assays on dried blood spot eluents
|
baseline
|
|
Circulating IL-6
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
|
Circulating CRP
Time Frame: baseline
|
assays on dried blood spot eluents
|
baseline
|
|
Circulating CRP
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
|
Circulating Total Cholesterol
Time Frame: baseline
|
assays on dried blood spot eluents
|
baseline
|
|
Circulating Total Cholesterol
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
|
Circulating HDL Cholesterol
Time Frame: baseline
|
assays on dried blood spot eluents
|
baseline
|
|
Circulating HDL Cholesterol
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
|
Circulating Tryglycerides
Time Frame: baseline
|
assays on dried blood spot eluents
|
baseline
|
|
Circulating Tryglycerides
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
|
Circulating Adiponectin
Time Frame: baseline
|
assays on dried blood spot eluents
|
baseline
|
|
Circulating Adiponectin
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
|
Circulating Leptin
Time Frame: baseline
|
assays on dried blood spot eluents
|
baseline
|
|
Circulating Leptin
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
|
Duke OARS Co-Morbidity Index
Time Frame: baseline
|
43-item assessment of co-morbid conditions (multiple choice) (modified by removing 1 item)
|
baseline
|
|
Duke OARS Co-Morbidity Index
Time Frame: 3 months
|
43-item assessment of co-morbid conditions (multiple choice) (modified by removing 1 item)
|
3 months
|
|
Duke OARS Co-Morbidity Index
Time Frame: 6 months
|
43-item assessment of co-morbid conditions (multiple choice) (modified by removing 1 item)
|
6 months
|
|
PROMIS v.1.2 GLOBAL HEALTH
Time Frame: Baseline
|
10-item Likert scale assessment of Quality of Life
|
Baseline
|
|
PROMIS v.1.2 GLOBAL HEALTH
Time Frame: 3 months
|
10-item Likert scale assessment of Quality of Life
|
3 months
|
|
PROMIS v.1.2 GLOBAL HEALTH
Time Frame: 6 months
|
10-item Likert scale assessment of Quality of Life
|
6 months
|
|
EQ-5D-5L
Time Frame: Baseline
|
6-item Likert scale assessment of Quality of Life
|
Baseline
|
|
EQ-5D-5L
Time Frame: 3 months
|
6-item Likert scale assessment of Quality of Life
|
3 months
|
|
EQ-5D-5L
Time Frame: 6 months
|
6-item Likert scale assessment of Quality of Life
|
6 months
|
|
HEALTH / E-HEALTH LITERACY SCALE (NORMAN 2006)
Time Frame: Baseline
|
7-item scale to assess e-health literacy.
Two items were added from eHEALS to understand consumer's interest in using eHealth in general.
|
Baseline
|
|
HEALTH / E-HEALTH LITERACY SCALE (NORMAN 2006)
Time Frame: 3 months
|
7-item scale to assess health and e-health literacy.
Two items were added from eHEALS to understand consumer's interest in using eHealth in general.
|
3 months
|
|
HEALTH / E-HEALTH LITERACY SCALE (NORMAN 2006)
Time Frame: 6 months
|
7-item scale to assess health and e-health literacy.
Two items were added from eHEALS to understand consumer's interest in using eHealth in general.
|
6 months
|
|
Barriers to Eating a Healthy Low Calorie Diet
Time Frame: Baseline
|
(10 items) Respondents either affirm or deny common barriers to low calorie diet.
|
Baseline
|
|
Barriers to Eating a Healthy Low Calorie Diet
Time Frame: 3 months
|
(10 items) Respondents either affirm or deny common barriers to low calorie diet.
|
3 months
|
|
Barriers to Eating a Healthy Low Calorie Diet
Time Frame: 6 months
|
(10 items) Respondents either affirm or deny common barriers to low calorie diet.
|
6 months
|
|
PROMIS Emotional Distress: Depression - Short Form 8a
Time Frame: Baseline
|
(8 items) Likert scale assessment of depression
|
Baseline
|
|
PROMIS Emotional Distress: Depression - Short Form 8a
Time Frame: 3 months
|
(8 items) Likert scale assessment of depression
|
3 months
|
|
PROMIS Emotional Distress: Depression - Short Form 8a
Time Frame: 6 months
|
(8 items) Likert scale assessment of depression
|
6 months
|
|
Smoking status
Time Frame: Baseline
|
2 items that ask whether respondent has ever smoked >100 cigarettes and current smoking status.
|
Baseline
|
|
Smoking status
Time Frame: 3 months
|
2 items that ask whether respondent has ever smoked >100 cigarettes and current smoking status.
|
3 months
|
|
Smoking status
Time Frame: 6 months
|
2 items that ask whether respondent has ever smoked >100 cigarettes and current smoking status.
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relationship to chosen partner
Time Frame: Baseline
|
1 item question that asks for relationship of chosen partner to cancer survivor
|
Baseline
|
|
Socio-Demographic (George, et al, 1984)
Time Frame: Baseline
|
3-items that ask about income and perceptions of economic well-being
|
Baseline
|
|
Socio-Demographic (George, et al, 1984)
Time Frame: 3 months
|
3-items that ask about income and perceptions of economic well-being
|
3 months
|
|
Socio-Demographic (George, et al, 1984)
Time Frame: 6 months
|
3-items that ask about income and perceptions of economic well-being
|
6 months
|
|
Circulating Insulin (TSH)
Time Frame: Baseline
|
assays on dried blood spot eluents
|
Baseline
|
|
Circulating Insulin (TSH)
Time Frame: 6 months
|
assays on dried blood spot eluents
|
6 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300003882
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
Clinical Trials on eHealth Intervention
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedRenal Insufficiency, Chronic | Kidney Failure, ChronicUnited States
-
Zagazig UniversityCompletedCancer | Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Egypt
-
University of Southern DenmarkOPEN - Odense Patient data Explorative Network, The University of Southern...CompletedDepression, AnxietyDenmark
-
Universitat de GironaCompletedAttention Deficit-hyperactivity DisorderSpain
-
Brock UniversityUniversity of TorontoCompleted
-
University of Alabama at BirminghamCompletedObesity | Diabetes | Spinal Cord InjuriesUnited States
-
Duke UniversityCompleted
-
Tilburg UniversityCompleted
-
Jinan University GuangzhouGuangzhou Sport UniversityCompletedObesity Prevention | Depression - Major Depressive Disorder | Psychological Well BeingChina
-
Universiteit LeidenHeliomare RevalidatieEnrolling by invitationFatigue | Acquired Brain InjuryNetherlands